Many cellular processes have been identified in which phosphatidylinositol
3-kinase has a key regulatory function. As an oncogene, it is also involved
in the development of cancer. The transformation and progression of normal
cells towards an advanced stage tumor and/or towards metastatic lesions in
volves a complex series of events, including genetic alterations, leading t
o aberrant cell cycle progression, altered adhesion and motility characteri
stics, inhibition of apoptosis and induction of angiogenesis. This review h
ighlights the processes involved in the pathogenesis of cancer in which pho
sphatidylinositol 3-kinase is involved and provides an overview of the poss
ible mechanisms by which the enzyme exerts its oncogenic action.